Menstruation adjustment

The term "menstruation adjustment" does not refer to a specific molecule, receptor, or biologically distinct target. Instead, menstruation is a physiological process regulated by the concerted action of hypothalamic, pituitary, ovarian, and uterine hormones and receptors, particularly involving gonadotropin-releasing hormone (GnRH), follicle-stimulating hormone (FSH), luteinizing hormone (LH), progesterone, and estradiol[3][5]. Therapeutic adjustment or management of menstruation typically involves targeting one or more of these hormones or their receptors. For example, selective progesterone receptor modulators (SPRMs) are used to target the progesterone receptor in the endometrium to modulate menstrual bleeding or disorders[1]. Additionally, estradiol and progesterone act via their nuclear and membrane-bound receptors to regulate gene expression and cell signaling throughout the endometrium and reproductive axis[4][5]. Drugs that interact with these targets can affect menstruation by influencing the hormonal feedback loops and endometrial physiology. If you are looking for molecular targets involved in menstrual regulation, relevant targets would include: - Progesterone receptor (targeted by SPRMs such as ulipristal acetate) - Estrogen receptor - Gonadotropin-releasing hormone receptor - Various enzymes and cytokines involved in inflammatory and reparative processes in the endometrium (e.g., COX-2, TNF, IL-6)[1]. However, "menstruation adjustment" is not itself a molecular or therapeutic target but a description of a therapeutic goal.